Start smart: A practical guide to winning with generative AI

Author : management consulting | Published On : 14 Sep 2026

Generative AI may well be one of the biggest technological shifts of our lifetimes. For companies that move with both speed and smarts, it represents an enormous opportunity. For those that wait, it is an equally large risk.

So where do you actually begin?

Understanding generative AI use cases

The first step is figuring out where to focus. Since large language models can perform so many tasks without additional training, the options can feel overwhelming. Most use cases today fall into one of four broad categories:

• Information synthesis: Pulling meaningful insights from massive volumes of unstructured text – something that once took weeks can now take days.

• Content generation: Producing tailored messaging at scale, designed for specific audiences without the manual effort.

• Answer engines: Going beyond search to deliver direct, synthesized answers from dense or unlabeled sources like research reports or training manuals.

• Agents: Reasoning through complex, multi-step business problems end to end, with minimal human instruction

A marathon, not a sprint — but speed still matters

Getting the most from generative AI in pharma and other industries requires moving through three stages:

• Stage 1: Automating discrete, repetitive tasks to free up human capacity

• Stage 2: Automating tasks alone will not create lasting advantage because anyone can do it. The next step is rethinking entire processes end to end, not just individual steps.

• Stage 3: Transforming how the organization operates at its core by reimagining not just how work gets done but what the work actually is.

Managing risk, the right way

Managing gen AI risk does not have to be complicated. The simplest advice: start where it is easiest and safest.

Evaluating risk

When looking at potential use cases, ask two questions:

• How sensitive is the data being used?

• Will a human review the output before it goes anywhere?

Start with use cases that use public data and have a human checking every output. Avoid anything involving personal data or fully automated outputs until AI safeguards are more mature.

Centralized vs. federated

Who does the work and who is responsible for the risks should guide this decision:

• If models use public data and outputs stay internal, go federated. It is faster and more flexible.

• If models use sensitive or third-party data and outputs go directly to clients, go centralized. It is the safer choice.

The time to act is now

Waiting is not a neutral decision. Every month spent on the sidelines is a month competitors use to build proprietary capabilities that are hard to catch up with. This is where medical devices consulting and broader technology expertise become valuable, helping organizations:

• Identify the highest-value use cases to pursue first

• Build the right data and technology infrastructure to support scale

• Manage the organizational change that comes with any serious AI deployment

For teams ready to commit, the path from pilot to competitive advantage is clearer than it has ever been. The organizations that will win are the ones that start now, learn fast and keep evolving.